Latest news for Pembina Pipeline (OTC:PBNAF) Stock

Pembina Pipeline

Pembina Pipeline is a midstream company serving the Canadian and North American (primarily Bakken) markets with an integrated product portfolio. Its assets include pipelines and gas gathering as well as assets across fractionation, storage, and propane exports.

PEMBINA PIPE PFD 5YR A 1 by Pembina Pipeline Corp.

Pembina Pipeline Corp

Morgan Stanley analyst Alexandra Steiger maintains TJX Companies (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TJX#NYSE">TJX</a>) with a Overweight and raises the price target from $113 to $122.

News

Price Target

Analyst Ratings

Morgan Stanley Maintains Overweight on TJX Companies, Raises Price Target to $122

Commodities

Markets

Reuters Reported OPEC+ Unlikely To Change Oil Output Policy At Aug 1 JMMC Meeting, Citing Sources

Cantor Fitzgerald analyst Troy Jensen initiates coverage on Impinj (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PI#NASDAQ">PI</a>) with a Overweight rating and announces Price Target of $205.

Initiation

Cantor Fitzgerald Initiates Coverage On Impinj with Overweight Rating, Announces Price Target of $205

Deutsche Bank analyst Krisztina Katai downgrades Five Below (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FIVE#NASDAQ">FIVE</a>) from Buy to Hold and lowers the price target from $155 to $79.

Downgrades

FIVE

Deutsche Bank Downgrades Five Below to Hold, Lowers Price Target to $79

Alliance Global Partners analyst Gaurav Mehta initiates coverage on UMH Properties (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/UMH#NYSE">UMH</a>) with a Buy rating and announces Price Target of $21.

Alliance Global Partners Initiates Coverage On UMH Properties with Buy Rating, Announces Price Target of $21

Offerings

General

LUXH

LuxUrban Hotels Announced That The Underwriter Of Its Underwritten Public Offering Has Exercised Its Over-allotment Option In Full To Purchase An Additional 4.5M Shares At The Public Offering Price Of $0.17/Share

The Company plans to report the final analysis from the IGNITE clinical trial, including all patients at 12 months dosed with either 20 mg/kg or 40 mg/kg of iluzanebart in the first half of 2025. &nbsp;

Biotech

Health Care

VIGL

Vigil Neuroscience Announced An Update Following A Type C Meeting With The FDA To Its Clinical Development Strategy For Its IGNITE Trial Of Iluzanebart For Adult-onset Leukoencephalopathy With Axonal Spheroids And Pigmented Glia

B of A Securities analyst Tomer Zilberman maintains Motorola Solns (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MSI#NYSE">MSI</a>) with a Buy and raises the price target from $370 to $440.

B of A Securities Maintains Buy on Motorola Solns, Raises Price Target to $440

B of A Securities analyst Elizabeth Suzuki maintains Leslies (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LESL#NASDAQ">LESL</a>) with a Buy and lowers the price target from $6.4 to $5.15.

LESL

B of A Securities Maintains Buy on Leslies, Lowers Price Target to $5.15

The energy storage solutions will be used for Root-Power&#39;s Coryton Energy Park project, in Corringham, Essex, England. Construction of the project started in late May 2024.

Contracts

CSIQ

Canadian Solar Announced That e-STORAGE, Part Of The Company's Majority-owned Subsidiary CSI Solar, Has Received A Contract For 11 MW AC/22 MWh AC Energy Storage Solutions From Root-power, Part Of The Ylem Group

Wayfair Plans Four Days Of Exclusive Sales For Black Friday In July; Up To 80% Off All Things Home July 26-29

WIIM

FTNT

Fortinet shares are trading higher after TD Cowen upgraded the stock from Hold to Buy.

B of A Securities analyst Heather Balsky maintains Equifax (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EFX#NYSE">EFX</a>) with a Buy and raises the price target from $255 to $286.

B of A Securities Maintains Buy on Equifax, Raises Price Target to $286

Sempra Infrastructure, A Subsidiary Of Sempra Announced Port Arthur LNG Phase 2 And Bechtel Energy Have Signed A Fixed-Price Engineering, Procurement And Construction Contract For The Port Arthur LNG Phase 2 Project Under Development In Port Arthur, Texas

BRKR

Bruker Posted Bond In Order To Suspend Injunction That Had Been Impacting Sales Of CosMx Spatial Molecular Imager Products By Its NanoString Business In Germany

MRNS

China National Medical Products Administration Has Approved Marinus Pharmaceuticals' Ganaxolone Oral Suspension For Epileptic Seizures In Patients Two Years Of Age And Older With CDKL5 Deficiency Disorder

Guidance

Hexcel Revised FY24 Outlook: Adj. EPS $2.02-$2.18 (From $2.10-$2.30) Vs. $2.21 Est., Revenue $1.90B-$1.98B (From $1.925B-$2.025B) Vs $1.955B Est.

B of A Securities analyst Kevin Fischbeck downgrades Elevance Health (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ELV#NYSE">ELV</a>) from Buy to Neutral and lowers the price target from $646 to $530.

streetTRACKS Dow Jones U.S. Large Cap Value Index Fund

B of A Securities Downgrades Elevance Health to Neutral, Lowers Price Target to $530

SYRA

Siyata Mobile shares are trading higher after the company announced new orders for its SD7 handsets and related accessories valued at more than $4.5 million in aggregate for US wireless carriers.

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Comments

Pembina Pipeline

News

Latest news for Pembina Pipeline (OTC:PBNAF) Stock